相关实验视频

Updated: Sep 11, 2025

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

在Mycobacterium tuberculosis中对β-Lactam抗生素多药学的全面鉴定

Kaylyn L Devlin¹, Emily Hutchinson¹, Hailey N Dearing¹

¹Department of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, Oregon 97239, United States.

ACS infectious diseases

|August 18, 2025

概括

新的研究表明,抗生素美罗胺针对结核菌菌 (Mtb) 中的30多种酶,通过多药理学提供了治疗结核病 (TB) 的新策略.

科学领域:

微生物学微生物学
药物发现药物发现药物发现
生物化学生物化学

背景情况:

由Mycobacterium tuberculosis (Mtb) 引起的结核病 (TB) 需要长时间的多种抗生素治疗.
新兴研究正在探索β-乳糖抗生素,以改善结核病治疗结果.
目前还没有完全了解Mtb中的β-乳酸目标.

研究的目的:

在模仿急性和慢性结核病的条件下,通过β-乳糖抗生素抑制的Mtb酶的识别和表征.
利用基于meropenem的新型基于活动的探针来精确识别药物标.

主要方法:

开发和应用基于meropenem的基于活动的探针.
使用与结核病相关的生理条件对酶抑制的表征.
对确定目标的β-乳酸结合和水解的验证.

主要成果:

识别超出已知的细胞壁生物合成酶的新型梅罗胺目标.
验证了六个新的目标:Rv1723,Rv2257c,Rv0309,DapE (Rv1202),MurI (Rv1338) 和LipD (Rv1923). 这些目标包括:
证明至少有30万亿个酶对美罗胺抑制有敏感性.

结论:

梅罗胺表现出多种药理,抑制了广泛的Mtb酶.
广泛的向表明,美罗的疗效与其多药作用之间存在直接联系.
这项研究扩大了Mtb中β-乳糖的已知点,为未来的结核病药物开发提供了信息.

关键词:

结核病菌菌菌的结核病菌的结核病菌.酵素酶是一种酶.酸甘油可以是酸甘油结核病是一种肺结核病.这是一种β-lactam抗生素.

更多相关视频

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria

Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria

Published on: December 14, 2016

相关概念视频

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Development of Antibiotic Resistance

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...